Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Hisse Senetlerindeki Sıralama #17309
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Hisse Fiyatı
$1.21
Piyasa Değeri
$248.41M
Değişim (1 gün)
4.11%
Değişim (1 yıl)
79.12%
Ülke
TW
Ticaret TWi Biotechnology, Inc. (6610)

Kategori

TWi Biotechnology, Inc. (6610) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.18 - 2026-09-01

Gün sonu en düşük fiyat: $1.95 - 2016-12-01
TWi Biotechnology, Inc. için hisse fiyatı geçmişi: 2016 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 43.11%
2025 36.47%
2024 -13.49%
2023 13.07%
2022 -19.33%
2021 0.82%
2020 81.49%
2019 -54.47%
2018 -43.81%
2017 -42.56%
2016 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$553.73 38.09%
US
$1.05K 47.97%
NL
$148.19 512.61%
US
$122.21 -10.03%
AU
$757.71 8.20%
CH